Skip to main content
School of Pharmacy

Dr. Simone Perazzolo is a Research Associate Scientist in the Department of Pharmaceutics at the University of Washington working in the TLC-ART Program. He holds a joint MSc from the University of Padua (Italy) and the University of Virginia (VA) where he worked on the Artificial Pancreas Project. In his role as a control engineer for an FDA-approved physiologically-based type I diabetes simulator, he studied the influence of insulin-sensitizer drugs on virtual populations under the supervision of Drs. Cobelli and Kovatchev, the founding fathers of SAAMII software. He received his Ph.D. in Biomedical Engineering from the University of Southampton (UK) with a thesis titled “Modelling the Nutrient Transfer across the Placenta”, under the supervision of Drs. Sengers and Lewis. Dr. Perazzolo has completed his 3-year postdoctoral fellowship at the UW School of Pharmacy with a track record of PK modeling publications about novel long-acting antiretroviral formulations for targeted long-acting HIV therapy, one of which secured the June 2020 front page of the Journal of Pharmaceutical Sciences. Currently, he works in Prof. Rodney Ho’s Lab supporting TLC-ART projects transforming short-acting into long-lasting therapies via computer simulations and projections of safety and efficacy. Long-acting therapies will replace daily pill intake in favor of just one injectable administration, like a “short-term vaccine”. Chronic diseases, such as HIV, but also cancer, and more recently, COVID-19, will benefit from these new pharmaceutical products. Simone has presented in several IEEE conferences and joined consortia focused on introducing Artificial Intelligence in drug development. He was recently interviewed by Italian national TV at the early stages of the COVID-19 pandemic in March 2020 with more than 2 million viewers.


Dr. Perazzolo list of publication can be found as follows: